Cécile Laude

Cécile Laude is an expert in Radiotherapy at Centre Léon Bérard (France). Cécile Laude has authored 22 publications, the most recent in 2027, and is an investigator in 5 clinical trials, 3 of them ongoing. SLR score: 147 (community average: 125). How the SLR is computed.

Radiotherapy

Subspecialties: Oncology - Medical Imaging - Urology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on September 1, 2026

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2009 - 2027

Source: PubMed

Centre Léon Bérard

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 22

Citations

Citations: 272 1st author: 3 Last author: 1 Unique author: 0

Main journals

Cancer Radiother 7

Int J Radiat Oncol Biol Phys 3

Cancers (Basel) 2

BMC Public Health 1

Bull Cancer 1

Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title	Journal	Year	Citations
Study Protocol of OLIGOPELVIS 2-GETUG P12: A Randomized Phase 3 Study Comparing Intermittent Androgen-deprivation Therapy with or Without Salvage High-dose Intensity-modulated Radiotherapy to Oligorecurrent Pelvic and Para-aortic Lymph Nodes in Patients with Biochemically Relapsing Prostate Cancer. PMID 42276876 — radiotherapy, intensity-modulated, radiotherapy, lymph nodes, androgens, neoplasms, prostate, urologic neoplasms, lymph, prostatic neoplasms, therapeutics	Eur Urol Oncol	2026	0
OLIGOPELVIS 2-GETUG P12- elective nodal radiotherapy for oligorecurrent pelvic/para-aortic nodes in prostate cancer: early toxicity of a randomized phase 3 trial. PMID 42140755 — radiotherapy, lymph nodes, neoplasms, prostate, lymph, prostatic neoplasms, beds, therapeutics	Radiother Oncol	2027	0
Evaluation of a quasi-automatic treatment planning workflow for head-and-neck cancer in radiotherapy. PMID 42088600 — radiotherapy, safety, workflow, neoplasms, head and neck neoplasms, therapeutics	Phys Imaging Radiat Oncol	2026	0
Single-Dose Radiation Therapy for Localized Prostate Cancer: Where Does the Evidence Lead? PMID 40227716 — radiotherapy, brachytherapy, neoplasms, prostate, prostatic neoplasms, therapeutics	Cancers (Basel)	2025	0
Case report of the first use of a hydrogel rectal spacer for prostate cancer reirradiation via LDR brachytherapy: applications and technical notes. PMID 39949746 — hydrogel, polyethylene glycol dimethacrylate, hydrogels, safety, brachytherapy, neoplasms, prostate, re-irradiation, prostatic neoplasms, therapeutics, tissues, radiation exposure	Front Oncol	2025	1

Clinical Studies 5

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 2

By phase:

N/A 5

By status:

Not yet recruiting 2

Active not recruiting 1

Completed 1

Recruiting 1

By type:

Interventional 4

Observational 1

By Monocentric/Multicentric:

monocentric 1

multicentric2to4 1

multicentric5to9 0

multicentricup10 3

Main Topics

Male Urogenital Diseases 2

Ongoing Clinical Trials

3 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study	Phase	Status	Start
Assessing the Ompact of Neutral Pelvic Positioning on Bone Repositioning Quality in Pelvic Radiotherapy Patients NCT06687200 — radiotherapy, radiotherapy, image-guided, tomography	N/A	Not yet recruiting	2024
Contribution of Multicenter Expertise and Deformable Fusion Software for Re irradiations With Curative Intent NCT06668038 — radiotherapy, re-irradiation, diagnosis, software	N/A	Recruiting	2024
Impact of a Physical Activity Intervention With Motivational Support From Peers for Prostate Cancer Patients NCT05739565 — exercise, neoplasms, pathology, prostate, prescriptions, motor activity, prostatic neoplasms, research, sports	N/A	Recruiting	2023

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS

Shopping Cart

System Maintenance Notice